<?xml version="1.0" encoding="UTF-8"?>
<p>Rare instances of neurological manifestations from patients in Taiwan were reported by Tsai et al.
 <sup>
  <xref rid="r45" ref-type="bibr">45</xref>
 </sup>, which included five cases of large-vessel ischemic stroke, three cases of axonal polyneuropathy, two cases of myopathy and three cases of rhabdomyolysis, all of them occurring a few weeks after the onset of the 2003 SARS epidemic caused by SARS-CoV. There was evidence of muscle weakness and raised creatine kinase levels in patients who had previously suffered from SARS-CoV infection.
 <sup>
  <xref rid="r46" ref-type="bibr">46</xref>,
  <xref rid="r47" ref-type="bibr">47</xref>
 </sup> However, a direct attack on the nervous system by the virus could not be determined conclusively, and these cases were considered to belong to the spectrum of critical illness neuropathy and myopathy or developing as a result of steroid use or cachectic disuse atrophy and weakness following long-term bed rest.
 <sup>
  <xref rid="r46" ref-type="bibr">46</xref>,
  <xref rid="r47" ref-type="bibr">47</xref>
 </sup> Autopsy studies in patients showed cerebral edema, meningeal vasodilatation, lymphocytic infiltration and ischemic demyelination of neurons; in some instances, viral particles and genome sequences of SARS-CoV were detected.
 <sup>
  <xref rid="r48" ref-type="bibr">48</xref>–
  <xref rid="r51" ref-type="bibr">51</xref>
 </sup>
</p>
